$GTXI & Oncternal Thx Enter into Definitive Merger Agreement to Create NasdaqListed ClinicalStage Company Developing a Diverse Pipeline of Novel Cancer Therapies httpswww.businesswire.comnewshome20190307005220enGTxOncternalTherapeuticsEnter

$GTXI & Oncternal Thx Enter into Definitive Merger Agreement to Create Nasdaq-Listed Clinical-Stage Company Developing a Diverse Pipeline of Novel Cancer Therapies https://www.businesswire.com/news/home/20190307005220/en/GTx-Oncternal-Therapeutics-Enter-

07:01 EST 7 Mar 2019 | Odi Bruckman

$GTXI & Oncternal Thx Enter into Definitive Merger Agreement to Create Nasdaq-Listed Clinical-Stage Company Developing a Diverse Pipeline of Novel Cancer Therapies https://www.businesswire.com/news/home/20190307005220/en/GTx-Oncternal-Therapeutics-Enter-Definitive-Merger-Agreement …

More From BioPortfolio on "$GTXI & Oncternal Thx Enter into Definitive Merger Agreement to Create Nasdaq-Listed Clinical-Stage Company Developing a Diverse Pipeline of Novel Cancer Therapies https://www.businesswire.com/news/home/20190307005220/en/GTx-Oncternal-Therapeutics-Enter-"